Table 2.

Summary of study characteristics (n = 19)

Characteristic	Number (%)
Year of publication
2013	1 (5.3%)
2014	2 (10.5%)
2015	1 (5.3%)
2016	2 (10.5%)
2017	2 (10.5%)
2018	5 (26.3%)
2019	6 (31.6%)
Geographic region
North America	16 (84.2%)
United Kingdom	2 (10.5%)
Australia	1 (5.3%)
Evaluation design
Observational	3 (15.8%)
Descriptive	1 (5.3%)
Experimental	3 (15.8%)
Qualitative	3 (15.8%)
Mixed methods	3 (15.8%)
System description	6 (31.6%)
Study setting
Outpatient or clinic	14 (73.7%)
Cancer center	3 (15.8%)
Academic medical center	2 (10.5%)
Target population
Diabetes	8 (42.1%)
Cancer	4 (21.1%)
Hypertension	2 (10.5%)
Orthopedic surgery	2 (10.5%)
Multiple conditions	2 (10.5%)
Prostate-specific antigen screening	1 (5.3%)